このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

小児睡眠診断技術の臨床評価

2026年11月13日 更新者:Acurable Ltd.

The objective of this project is to gather research data and subsequently evaluate algorithms to demonstrate clinical efficacy of a novel sleep apnoea detection system in the paediatric population.

The Study will involve patients who will have been referred for diagnosis of sleep apnoea, and the ultimate aim will be to compare the output of a novel apnoea detection system against in -clinic polysomnography or cardio-respiratory polygraphy, assess acceptance of the novel system in the home environment, assess validity in patients on ventilation, and on a cohort with BMI SDS of 3 or more.

調査の概要

詳細な説明

The objective of this project is to gather research data and subsequently evaluate algorithms to demonstrate clinical efficacy of a novel sleep apnoea detection system in the paediatric population.

The Study will involve patients who will have been referred for diagnosis of sleep apnoea, and the ultimate aim will be to compare the output of a novel apnoea detection system against in -clinic polysomnography or cardio-respiratory polygraphy, assess acceptance of the novel system in the home environment, assess validity in patients on ventilation, and on a cohort with BMI SDS of 3 or more.

Patients who are referred to the clinic for the first and second group will spend one night's sleep in the clinic for group 1 and group 2. They will wear a polysomnography or cardio-respiratory polygraphy system (current goldstandard) and the novel device. At the end of the trial, we will compare the diagnosis results from both systems.

Patients who are referred for home diagnosis of sleep apnoea or overnight oximetry at home (group 3) will wear the standard clinical sleep test system and the novel device. At the end of the trial, the acceptability of the novel device will be assessed.

Patients who are on mechanical ventilation and referred for diagnosis of sleep apnoea in hospital or at home will wear the standard clinical sleep test system and the novel device. At the end of the trial, the validity of the diagnosis from the novel device will be assessed.

Patients who are referred for either at home or in hospital diagnosis of sleep apnoea with a BMI SDS score of 3 or more will wear the standard clinical sleep test system and the novel device. At the end of the trial, we will compare the diagnosis results from both systems.

研究の種類

観察的

入学 (推定)

345

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

      • Sheffield、イギリス、S10 2TH
        • 募集
        • Sheffield Children Hospital
        • コンタクト:
        • 主任研究者:
          • Heather Elphick
      • Southampton、イギリス
        • 募集
        • Southampton Children's Hospital
        • コンタクト:
          • Orsina Dessi
        • 主任研究者:
          • Hazel Evans

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

1年~18年 (子、大人)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

サンプリング方法

確率サンプル

調査対象母集団

all children who have been referred for a sleep test.

説明

Inclusion Criteria:

  • Children older than one year old (older than eight years old for studies at-home) and below 18 years of age.
  • Children who have been referred to a sleep clinic due to suspicion of sleep apnoea.

Exclusion Criteria:

  • Patients whose parents/legal guardians/carers are not fluent in English, or who have special communication needs.
  • Known allergy to the adhesive dressing.
  • Patients with physical or mental impairments who would be too distressed with additional sensors on themselves.
  • Patients with not enough space on the neck area to fit the sensor.
  • Clinical problem in the area in which the device will be attached, eg skin condition ●. For patients conducting the study at home, patients with neurocognitive impairments which may increase the risk of them putting the sensor in their mouth, who do not have overnight carers

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 観測モデル:COHORT
  • 時間の展望:PROSPECTIVE

コホートと介入

グループ/コホート
介入・治療
test group

Test group will wear PSG

The patient will wear the novel wearable paediatric device at the same time as polysmnography

Novel wearable device

THis group will wear the novel device

The patient will wear the novel wearable paediatric device at the same time as polysmnography

Home

40 consecutive patients (plus/minus 30% to account for potential dropouts, invalid signals from the gold-standard), who will have been referred for at home diagnosis of sleep apnoea or overnight oximetry at home. Each site will recruit, in parallel, consecutive patients from the moment the first patient in this group is recruited at that site. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. Criteria for inclusion are children older than 8 years old and referral for overnight assessment for evaluation of possible sleep apnoea. Additionally, patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. This patient cohort will be used to assess the acceptance of the AcuPebble technology in the home environment.

The patient will wear the novel wearable paediatric device at the same time as polysmnography

Ventilation

30 patients will be recruited (plus/minus 30% to account for potential dropouts, invalid signals from the gold-standard), who are on mechanical ventilation and have been referred for diagnosis of sleep apnoea. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. Criteria for inclusion are children older than 1 year old, referral for overnight assessment for evaluation or monitoring of sleep apnoea, and being on mechanical ventilation while conducting the study in hospital, or over 8 years old, referral for overnight assessment for evaluation or monitoring of sleep apnoea, and being on mechanical ventilation while conducting the study at home. Patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. These patients will be included in a final analysis of diagnostic validity.

The patient will wear the novel wearable paediatric device at the same time as polysmnography

High BMI

75 patients will be recruited (plus/minus 30% to account for potential dropouts, or invalid signals from the gold-standard), who have a BMI SDS score of 3 or more and have been referred for either at-home or in-hospital diagnosis of sleep apnoea. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. If their study is to take place in the home, only children who are older than 8 will be included. If their study is to take place in hospital, children over the age of 1 will be included. Patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. These patients will be included in a final analysis of sensitivity and specificity for this cohort.

The patient will wear the novel wearable paediatric device at the same time as polysmnography

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Specificity and sensitivity of novel device
時間枠:6 months

specificity and sensitivity of the output of the novel wearable device against polysomnography

6 months

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • スタディディレクター:Ruth Kingshott, PhD、Sheffield Children's NHS Foundation Trust

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2020年2月19日

一次修了 (推定)

2027年10月14日

研究の完了 (推定)

2027年10月14日

試験登録日

最初に提出

2019年7月23日

QC基準を満たした最初の提出物

2019年7月23日

最初の投稿 (実際)

2019年7月25日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月18日

QC基準を満たした最後の更新が送信されました

2026年11月13日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する